Other stroma-targeted strategies include CSF-1R, CXCR1, CXCR2, and CCR2/CCR5 blockades, which inhibit the trafficking and recruitment of myeloid cells such as macrophages into the tumor [380,381]. Here, CXCR2 is linked to neoplasm.